We are committed to bringing improved medicines to patients as quickly as possible. This means creating efficient product development and clinical translation processes. We retain in-house control of the critical elements of drug development. At our operational headquarters in the UK, a diverse team of interdisciplinary scientists are optimizing new product candidates in our new state-of-the-art research complex. Experienced, dedicated personnel are creating quality-controlled products in our GMP cell and gene manufacturing suites. Our clinical group are working directly with physicians and hospitals around the world.